Jeffrey D. Marrazzo - 10 May 2023 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director
Signature
/s/ Marishka DeToy, attorney-in-fact
Issuer symbol
PRME
Transactions as of
10 May 2023
Net transactions value
$0
Form type
4
Filing time
12 May 2023, 16:30:00 UTC
Next filing
04 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +92,000 $0.000000 92,000 10 May 2023 Common Stock 92,000 $14.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in three equal annual installments beginning on May 10, 2024, subject to the Reporting Person's continued service on each such vesting date.